These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 27328443)

  • 1. Non-invasive assessment of the antipsoriatic activity of fumaric acid derivatives.
    Hoffmann K; Dirschka T; Schwarze H; Stücker M; Matthes U; El-Gammal S; Hoffmann A; Altmeyer P
    Skin Res Technol; 1995 Aug; 1(3):145-51. PubMed ID: 27328443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 20 MHz sonography, colorimetry and image analysis in the evaluation of psoriasis vulgaris.
    Hoffmann K; Dirschka T; Schwarze H; el-Gammal S; Matthes U; Hoffmann A; Altmeyer P
    J Dermatol Sci; 1995 Mar; 9(2):103-10. PubMed ID: 7772572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [100 MHz ultrasound of psoriasis vulgaris plaque].
    el Gammal S; Pieck C; Auer T; Kaspar K; Hoffmann K; Altmeyer P; Vogt M; Ermert H
    Ultraschall Med; 1998 Dec; 19(6):270-4. PubMed ID: 10028562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peroral long-term treatment of psoriasis using fumaric acid derivatives].
    Bayard W; Hunziker T; Krebs A; Speiser P; Joshi R
    Hautarzt; 1987 May; 38(5):279-85. PubMed ID: 3112040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of psoriasis with non-registered fumaric acid esters in The Netherlands: a nationwide survey among Dutch dermatologists.
    Fallah Arani S; Balak DM; Neumann HA; Kuipers MV; Thio HB
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):972-5. PubMed ID: 23822581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients.
    Kokelj F; Plozzer C; Avian A; Trevisan G
    Acta Dermatovenerol Croat; 2009; 17(3):170-5. PubMed ID: 19818215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.
    Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH
    Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunomodulation with fumaric acid. Systemic therapy in psoriasis].
    Sebók B; Schneider I
    Orv Hetil; 2000 Jan; 141(3):129-32. PubMed ID: 10693335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psoriasis therapy with fumaric acid and fumaric acid esters].
    Raab W
    Z Hautkr; 1984 May; 59(10):671-9. PubMed ID: 6741206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis: report on 17 cases.
    Wilsmann-Theis D; Frambach Y; Philipp S; Weyergraf AJ; Jacobi A; Mössner R; Gerdes S
    Dermatology; 2015; 230(2):119-27. PubMed ID: 25661583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria with fumaric acid ester treatment for psoriasis.
    Ogilvie S; Lewis Jones S; Dawe R; Foerster J
    Clin Exp Dermatol; 2011 Aug; 36(6):632-4. PubMed ID: 21771009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic treatment with fumaric acid esters in six paediatric patients with psoriasis in a psoriasis centre.
    Steinz K; Gerdes S; Domm S; Mrowietz U
    Dermatology; 2014; 229(3):199-204. PubMed ID: 25247273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fumaderm® in daily practice for psoriasis: dosing, efficacy and quality of life.
    Walker F; Adamczyk A; Kellerer C; Belge K; Brück J; Berner T; Merten K; Núnez Gómez N; Neureither M; Röcken M; Ghoreschi K;
    Br J Dermatol; 2014 Nov; 171(5):1197-205. PubMed ID: 24813676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands.
    Balak DM; Oostveen AM; Bousema MT; Venema AW; Arnold WP; Seyger MM; Thio HB
    Br J Dermatol; 2013 Jun; 168(6):1343-7. PubMed ID: 23738641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of fumaric acid esters on cardiovascular risk factors and depression in psoriasis: a prospective pilot study.
    Schmieder A; Poppe M; Hametner C; Meyer-Schraml H; Schaarschmidt ML; Findeisen P; Benoit S; Bauer B; Schmid S; Goebeler M; Goerdt S; Ludwig-Peitsch WK
    Arch Dermatol Res; 2015 Jul; 307(5):413-24. PubMed ID: 25648959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteomalacia as an apparently rare side effect of oral fumaric acid therapy. Secondary DeToni-Debré Fanconi syndrome in the adult].
    Fliegner L; Spiegel P
    Hautarzt; 1992 Sep; 43(9):554-60. PubMed ID: 1399600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
    Balasubramaniam P; Stevenson O; Berth-Jones J
    Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters.
    Werdenberg D; Joshi R; Wolffram S; Merkle HP; Langguth P
    Biopharm Drug Dispos; 2003 Sep; 24(6):259-73. PubMed ID: 12973823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
    Lecha M; Mirada A; López S; Artés M;
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A.
    Schopf RE; Hultsch T; Lotz J; Bräutigam M
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):234-9. PubMed ID: 9883435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.